Publication|Videos|December 18, 2023
Adaptable Formulation Development Strategies for Today with a Focus on Tomorrow
Author(s)Serán
Wesley Tatum, PhD (Principal Engineer, Process & Product Development, Serán Bioscience) shares insights surrounding formulation and process development that focus on the future of the industry.
At the 2023 American Association of Pharmaceutical Scientists (AAPS) conference, Pharmaceutical Technology spoke with Serán's Wesley Tatum, PhD, about formulation strategies that consider the future of the industry. Learn more about:
- Leveraging expertise in material science and particle engineering. Serán addresses the industry’s most challenging problem statements in drug development.
- How a partnership philosophy that emphasizes creativity and collaboration enables rapid development of advanceable formulations and processes with minimal material.
- Identifying the best strategy and formulation technology for each program’s unique considerations and needs.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
![[Rishi Pimentel, gChem]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/16bc98940a34f0991f9ca5e7ccbfa6889fec078f-1634x909.jpg?w=350&fit=crop&auto=format)
![[Rishi Pimentel, gChem]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/01d391920288b8bd8b751988988b5a6544a6ddaa-1629x908.jpg?w=350&fit=crop&auto=format)
![[Nigel Langley]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/e2c0137d8224aaa1f14c0f1af43b58d21f4541dd-1768x904.jpg?w=350&fit=crop&auto=format)
Trending on Pharmaceutical Technology
1
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
2
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
3
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
4
How a “Plan, Prevent, Prove” Approach Helps Avoid Facility and Equipment Problems
5
